Mobile

A Double Blinded, Placebo Controlled, Study to Investigate the Safety, Tolerability, Pharmacokinetics and Acute Cardiovascular Responses of a 7 Day Oral Treatment With the Partial Adenosine A1 Recepto...

Update Il y a 4 ans
Reference: DRKS00005890

A Double Blinded, Placebo Controlled, Study to Investigate the Safety, Tolerability, Pharmacokinetics and Acute Cardiovascular Responses of a 7 Day Oral Treatment With the Partial Adenosine A1 Receptor Agonist BAY1067197 in Patients With Chronic Systolic Heart Failure: the PARSiFAL-pilot Study

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

Inclusion criteria

  • Heart failure,I50 - Heart failure

Links